Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Beach

Showing results (191-200 of 653) with videos related to

Pageof 66
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 5, 2015
[(18)F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: specific detection of advanced phases of amyloid-β pathologyDietmar Rudolf Thal, Thomas G Beach, Michelle Zanette, et al.
Neuroscience Letters|October 11, 2003
Thiorphan-induced neprilysin inhibition raises amyloid beta levels in rabbit cortex and cerebrospinal fluidAmanda J Newell, Lucia I Sue, Sarah Scott, et al.
Archives of Neurology|December 19, 2006
Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal agingMarwan N Sabbagh, Flora Shah, Richard T Reid, et al.
Acta Neuropathologica|May 3, 2011
Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer's diseasePamela E Potter, Paula K Rauschkolb, Yoga Pandya, et al.
Brain Research|March 28, 2025
Reduction in [<sup>18</sup>F]Nifene Binding, a PET imaging Probe for α4β2* Nicotinic acetylcholinergic receptors in Hippocampus-Subiculum of postmortem human Alzheimer's disease brainFariha Karim, Allyson Ngo, Tram B Danh, et al.
Analytical and Bioanalytical Chemistry|March 27, 2025
Development and validation of a multiclass LC-MS/MS method for the analysis of cyanotoxinsLydia Zamlynny, Hannah M Morris, Sabrina D Giddings, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 22, 2017
Genetic analysis of α-synuclein 3' untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodiesLidia Tagliafierro, Omolara-Chinue Glenn, Madison E Zamora, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 31, 2018
Probing the striatal dopamine system for a putative neuroprotective effect of deep brain stimulation in Parkinson's diseaseGian Pal, Bichun Ouyang, Leo Verhagen, et al.
Toxicon : Official Journal of the International Society on Toxinology|January 26, 2026
Anatoxin biosynthesis gene abundance correlates with anatoxin concentration in freshwater benthic samplesJoshua R Evans, Daniel G Beach, Jake Stillwell, et al.
Movement Disorders Clinical Practice|May 17, 2024
Parkinson's Disease Associated with G2019S LRRK2 Mutations without Lewy Body PathologyLauren M Jackson, Bryan K Woodruff, Cecilia Tremblay, et al.
Pageof 66

Showing results (191-200 of 653) with videos related to

Sort By:
Pageof 66
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 5, 2015
[(18)F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: specific detection of advanced phases of amyloid-β pathologyDietmar Rudolf Thal, Thomas G Beach, Michelle Zanette, et al.
Neuroscience Letters|October 11, 2003
Thiorphan-induced neprilysin inhibition raises amyloid beta levels in rabbit cortex and cerebrospinal fluidAmanda J Newell, Lucia I Sue, Sarah Scott, et al.
Archives of Neurology|December 19, 2006
Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal agingMarwan N Sabbagh, Flora Shah, Richard T Reid, et al.
Acta Neuropathologica|May 3, 2011
Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer's diseasePamela E Potter, Paula K Rauschkolb, Yoga Pandya, et al.
Brain Research|March 28, 2025
Reduction in [<sup>18</sup>F]Nifene Binding, a PET imaging Probe for α4β2* Nicotinic acetylcholinergic receptors in Hippocampus-Subiculum of postmortem human Alzheimer's disease brainFariha Karim, Allyson Ngo, Tram B Danh, et al.
Analytical and Bioanalytical Chemistry|March 27, 2025
Development and validation of a multiclass LC-MS/MS method for the analysis of cyanotoxinsLydia Zamlynny, Hannah M Morris, Sabrina D Giddings, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 22, 2017
Genetic analysis of α-synuclein 3' untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodiesLidia Tagliafierro, Omolara-Chinue Glenn, Madison E Zamora, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 31, 2018
Probing the striatal dopamine system for a putative neuroprotective effect of deep brain stimulation in Parkinson's diseaseGian Pal, Bichun Ouyang, Leo Verhagen, et al.
Toxicon : Official Journal of the International Society on Toxinology|January 26, 2026
Anatoxin biosynthesis gene abundance correlates with anatoxin concentration in freshwater benthic samplesJoshua R Evans, Daniel G Beach, Jake Stillwell, et al.
Movement Disorders Clinical Practice|May 17, 2024
Parkinson's Disease Associated with G2019S LRRK2 Mutations without Lewy Body PathologyLauren M Jackson, Bryan K Woodruff, Cecilia Tremblay, et al.
Pageof 66